TechTarget, Inc. Common Stock
$ 3.70
-0.54%
05 Mar - close price
- Market Cap 268,427,000 USD
- Current Price $ 3.70
- High / Low $ 3.93 / 3.62
- Stock P/E N/A
- Book Value 8.29
- EPS -14.39
- Next Earning Report 2026-03-11
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.03 %
- ROE -2.75 %
- 52 Week High 15.55
- 52 Week Low 3.41
About
TechTarget, Inc. provides business impact sales and marketing services for business technology companies in North America and internationally. The company is headquartered in Newton, Massachusetts.
Analyst Target Price
$11.67
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-10 | 2025-07-01 | 2025-06-03 | 2024-12-31 | 2024-11-06 | 2024-08-08 | 2024-05-09 | 2024-02-07 | 2023-11-08 | 2023-08-08 | 2023-05-09 | 2023-02-09 |
| Reported EPS | -1.07 | -7.32 | 0.4869 | 0.2131 | 0.42 | 0.42 | 0.31 | 0.42 | 0.43 | 0.45 | 0.41 | 0.68 |
| Estimated EPS | 0.4463 | 0.3613 | 0.445 | 0.49 | 0.37 | 0.41 | 0.34 | 0.37 | 0.36 | 0.4 | 0.36 | 0.52 |
| Surprise | -1.5163 | -7.6813 | 0.0419 | -0.2769 | 0.05 | 0.01 | -0.03 | 0.05 | 0.07 | 0.05 | 0.05 | 0.16 |
| Surprise Percentage | -339.749% | -2126.0172% | 9.4157% | -56.5102% | 13.5135% | 2.439% | -8.8235% | 13.5135% | 19.4444% | 12.5% | 13.8889% | 30.7692% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-11 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: TTGT
2026-03-05 20:51:34
The rise of AI agents that can generate applications from natural language inputs is disrupting the traditional Software as a Service (SaaS) market, leading some to fear a "SaaSpocalypse." While major SaaS vendors' stocks have been impacted, industry leaders believe that SaaS is not facing extinction but is evolving. Enterprises are now using AI to develop custom, in-house applications and even becoming SaaS providers themselves, shifting the value proposition and long-term revenue growth for established SaaS companies.
2026-03-05 19:51:34
Eli Lilly has launched Employer Connect, a direct-to-employer platform aimed at increasing access to its weight-loss drug Zepbound for U.S. employees. The platform connects employers with program administrators and pharmacies to make obesity care more affordable and transparent, offering all doses of Zepbound KwikPen to network pharmacies at $449. This initiative addresses the high cost and complexity of GLP-1 drug coverage, which significantly impacted large employers' prescription drug spending last year.
2026-03-05 18:51:34
Clover Health has become the first payer to go live on a CMS aligned network, meeting the interoperability standard set by the Centers for Medicare & Medicaid Services (CMS). Partnering with Kno2 and utilizing its technology arm, Counterpart Health, Clover Health can now respond in real-time to patient requests for clinical and claims data using standardized FHIR formats. This move aligns with a broader CMS initiative launched in July 2025 to improve information sharing and increase the availability of personalized tools for patients.
2026-03-05 13:51:34
Salesforce has launched new Agentforce Health AI agents aimed at automating time-consuming tasks for frontline healthcare workers such as data entry, lookup, and summarization. These agents, including Referrals and Assessment Agent and EHR Read-Write Agent, are designed to free up healthcare providers for more direct patient interaction. The rollout also includes new EHR integrations and partnerships, with a focus on tactical AI solutions that address the inefficiencies healthcare workers face.
2026-03-05 10:51:34
French startup Biomemory acquired Boston-based Catalog Technologies to accelerate the development of DNA-based data storage, aiming to make it a commercially viable alternative to magnetic tape for archival data. The acquisition provides Biomemory with key patents, infrastructure, and experts, pushing forward their goal to launch commercial products like 3D printers and DNA storage cards for data centers within 2-3 years. Despite skepticism from analysts regarding market size and practical challenges, Biomemory highlights DNA's long lifespan and potential cost savings.
2026-03-04 19:52:44
The article discusses how observability expands IT security beyond traditional monitoring, enabling deeper threat detection, predictive risk insight, faster response, and stronger forensics. It emphasizes the need for organizations to integrate observability tools with existing security practices and retrain personnel to effectively combat and anticipate security attacks, especially with the growing concerns around AI data and systems. Observability provides granular visibility into networks, containers, and applications, helping identify and proactively seal off potential security vulnerabilities.

